1.
Berto P, Bellone M, Sabinot A, Pinto C, Martino M, Generali D, et al. Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy. FE [Internet]. 2022 Feb. 2 [cited 2025 Jul. 23];23(1). Available from: https://provafe.seedstm.com/index.php/FE/article/view/1516